COVID-19 Rapid Diagnostic Test Market, By Product Type, By Sample Type, By Test Type, By End User, By Geography

Description

COVID-19 Rapid Diagnostic Test Market is estimated to be valued at USD 4,900 Mn in 2026 and is expected to reach USD 6,600.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4,900 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.30%	2033 Value Projection:	USD 6,600.0 Mn

A rapid diagnostic test of a sample of a person helps to detect the presence of viral proteins (antigens) related to the COVID-19 virus. This ensures an accurate and a speedy diagnosis, and its usage is Centers for Disease Control and Prevention CDC-approved. This test is a rapid diagnostic test based on antigen detection. The other test is rapid diagnostic test based on antibody detection. This test is used to detect the presence of antibodies in the blood of COVID-19 infected people. The strength of the antibody response depends on several factors like medications, age, infections, and the severity of disease, etc.

Molecular and antigen tests are types of diagnostic tests that can detect the infection if you have an active COVID-19 infection. Samples for diagnostic tests are normally collected with a throat or nasal swab, or saliva collected by spitting into a tube. Antibody tests look for antibodies in your immune system produced in response to SARS-CoV-2, the virus that is responsible for causing COVID-19. Antibody tests cannot be used to diagnose an active COVID-19 infection. Antibodies can take several days or weeks to develop after you get infected by the infection and may stay in your blood for several weeks or even after recovery from the infection. Samples for antibody tests are typically blood drawn by your doctor or other medical personnel.

Market Dynamics

The increasing number of approvals for new and advanced COVID-19 rapid diagnostic test kits by regulatory authorities is expected to propel the market growth over the forecast period. For instance, on May 12, 2020, Fujirebio Europe received CE mark for the molecular IVD assay iAMP COVID-19 detection kit, developed in partnership with Atila Biosystems, Inc., a U.S.-based company focused on developing products for nucleic acid amplification and detection of clinical diagnostic applications. Moreover, in September 2020, the U.S. FDA granted emergency use status to MiraDx, a U.S.-based molecular genetics company, for its SARS-CoV-2 RT-PCR assay used for detection of COVID-19.

Furthermore, development of cheaper COVID-19 detection kits is expected to drive the global COVID-19 rapid diagnostic test market growth over the forecast period. For instance, in January 2021, the World Health Organization approved a rapid antigen test developed by UNICEF (United Nations International Children's Emergency Fund) for diagnosis of COVID-19 under emergency use. This COVID-19 diagnostic test is a low cost alternative to other more expensive COVID-19 test and is priced at US$ 2.55 per test. With the development of such low cost COVID-19 rapid diagnostic tests, low and middle income countries such as Bangladesh, Indonesia, and others would have more access to the COVID-19 diagnostic tests.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global COVID-19 rapid diagnostic test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche AG, Cardinal Health, Inc., Alfa Scientific Designs, Inc., Acon Laboratories, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., and Creative Diagnostics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global COVID-19 rapid diagnostic test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global COVID-19 rapid diagnostic test market

Market Segmentation

By Product Type Insights (Revenue, USD Mn, 2021 - 2033)
Instruments
Reagents and Kits
By Sample Type Insights (Revenue, USD Mn, 2021 - 2033)
Nasopharyngeal swab
Oropharyngeal swab
Nasal swab
Osteosarcoma
Blood
Others
By Test Type Insights (Revenue, USD Mn, 2021 - 2033)
Molecular Testing
Antigen based Testing
Antibody Testing
Others
By End User Insights (Revenue, USD Mn, 2021 - 2033)
Hospitals
Laboratories and Diagnostic Centers
Others
By Region Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa
Key Players
Abbott Laboratories
Hoffmann-La Roche AG
Cardinal Health, Inc.
Alfa Scientific Designs, Inc.
Acon Laboratories, Inc.
Thermo Fisher Scientific Inc.
Danaher Corporation
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
Creative Diagnostics

Product Code: CMI4568

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Sample Type
- Market Snapshot, By Test Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Global COVID-19 Rapid Diagnostic Test Market Insights

Market Dynamics
- Drivers
- Restraints
- Opportunity
Acquisition and collaboration scenario
Product launch / approvals
Industry Trends
Regulatory scenario
Regulatory Insights
PEST Analysis

4. Global COVID-19 Rapid Diagnostic Test Market, By Product Type, 2021 - 2033, (US$ Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global COVID-19 Rapid Diagnostic Test Market, By Sample Type, 2021 - 2033, (US$ Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Nasopharyngeal Swab
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Oropharyngeal Swab
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Nasal Swab
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Blood
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global COVID-19 Rapid Diagnostic Test Market, By Test Type, 2021 - 2033, (US$ Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Molecular Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Antigen Based Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Antibody Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

7. Global COVID-19 Rapid Diagnostic Test Market, By End User, 2021 - 2033, (US$ Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Laboratories and Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

8. Global COVID-19 Rapid Diagnostic Test Market, By Region, 2021 - 2033, (US$ Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
North America
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Mn)
  - U.K.
  - Germany
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries/Regions, 2021 - 2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Company Profiles

Abbott Laboratories
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hoffmann-La Roche AG
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cardinal Health, Inc.
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alfa Scientific Designs, Inc
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Acon Laboratories, Inc.
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific Inc
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Danaher Corporation
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PerkinElmer, Inc.
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Creative Diagnostics
- Company Highlights
- Components Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About us